Article History
Accepted: 19 March 2024
First Online: 12 April 2024
Declarations
:
: Takanori Yanai received personal fees from Real World Data Co., Ltd. Satomi Yoshida has no competing interests relevant to the content of this article. Koji Kawakami receives research funds from Eisai Co., Ltd., Kyowa Kirin Co., Ltd., OMRON Corporation, and Toppan Inc.; consulting fees from Advanced Medical Care Inc., JMDC Inc., and Shin Nippon Biomedical Laboratories Ltd.; executive compensation from Cancer Intelligence Care Systems, Inc.; and honoraria from Chugai Pharmaceutical Co., Ltd., and Pharma Business Academy.